Reckitt Benckiser Group’s (RKT) “Hold” Rating Reaffirmed at HSBC

Reckitt Benckiser Group (LON:RKT)‘s stock had its “hold” rating reaffirmed by HSBC in a research note issued on Thursday, Digital Look reports.

Reckitt Benckiser Group Stock Up 1.0 %

Shares of Reckitt Benckiser Group stock opened at GBX 4,151 ($51.67) on Thursday. Reckitt Benckiser Group has a 1 year low of GBX 4,102.64 ($51.07) and a 1 year high of GBX 6,570 ($81.79). The business has a 50-day moving average of GBX 4,928.11 and a two-hundred day moving average of GBX 5,345.05. The company has a market capitalization of £29.41 billion, a P/E ratio of 1,827.31, a price-to-earnings-growth ratio of 3.76 and a beta of 0.07. The company has a debt-to-equity ratio of 100.80, a current ratio of 0.64 and a quick ratio of 0.46.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.